Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK9 | P50750 | 20/20 | 0.68 |
| ▸ | CDK2 | P24941 | 8/20 | 0.68 |
| ▸ | CDK7 | P50613 | 4/20 | 0.68 |
| ▸ | CDK13 | Q14004 | 2/20 | 0.68 |
| ▸ | CDK12 | Q9NYV4 | 2/20 | 0.68 |
| ▸ | CCNT1 | O60563 | 19/20 | 0.61 |
| ▸ | CCNH | P51946 | 3/20 | 0.61 |
| ▸ | CDK4 | P11802 | 7/20 | 0.54 |
| ▸ | CCND1 | P24385 | 7/20 | 0.54 |
| ▸ | CCNA1 | P78396 | 7/20 | 0.54 |
| ▸ | CCNE1 | P24864 | 6/20 | 0.54 |
| ▸ | CDK3 | Q00526 | 6/20 | 0.54 |
| ▸ | CDK1 | P06493 | 5/20 | 0.54 |
| ▸ | CCNA2 | P20248 | 5/20 | 0.54 |
| ▸ | CDK6 | Q00534 | 3/20 | 0.54 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.54 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.54 |
| ▸ | CCNK | O75909 | 1/20 | 0.47 |
| ▸ | CDK14 | O94921 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25477310 | 0.93 | CDK9 (0.64) | CDK9CDK2CDK7CDK13CDK12 | |
| SCHEMBL25477262 | 0.91 | CDK9 (0.62) | CDK9CDK2CDK7CDK13CDK12 | |
| SCHEMBL25477398 | 0.90 | CDK9 (0.71) | CDK9CDK2CDK7CDK13CDK12 | |
| SCHEMBL25183570 | 0.90 | CDK9 (0.71) | CDK9CDK2CDK7CDK13CDK12 | |
| SCHEMBL21877702 | 0.85 | CDK9 (0.64) | CDK9CDK2CDK7CDK13CDK12 | |
| SCHEMBL21877635 | 0.85 | CDK9 (0.64) | CDK9CDK2CDK7CDK13CDK12 | |
| SCHEMBL25477297 | 0.85 | CDK9 (0.64) | CDK9CDK2CDK7CDK13CDK12 | |
| SCHEMBL25477270 | 0.85 | CDK9 (0.68) | CDK9CDK2CDK7CDK13CDK12 | |
| SCHEMBL25477275 | 0.84 | CDK9 (0.63) | CDK9CDK2CDK7CDK13CDK12 | |
| SCHEMBL25479245 | 0.84 | CDK9 (0.57) | CDK9CDK2CDK7CDK13CDK12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230158159-A1 | CHIMERIC DEGRADERS OF CYCLIN-DEPENDENT KINASE 9 AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230158159-A1 | CHIMERIC DEGRADERS OF CYCLIN-DEPENDENT KINASE 9 AND USES THEREOF | CDK9, CDK19, CRBN | CDK9 1/4885CDK2 11/4885CDK7 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.